drugset / Trial / NCT00259779

Comparison Between Symbicort® and Prednisolone in COPD

NCT00259779

Phase 3 Completed 120 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess if Symbicort forte Turbuhaler (during two weeks) is as effective as an oral course of prednisolone + Oxis Turbuhaler (during two weeks) for the treatment of an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start
2005-09
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 320 ug Inhaled
Subject Formoterol Other / unclassified 9 ug Inhaled
Subject Prednisolone Other / unclassified 30 mg Oral